The effective management of sleep-wake disorders is a key competency for pharmacists, requiring a nuanced understanding of both non-pharmacological and pharmacological strategies. As outlined in the Patient Care VII: Brain and Behavior curriculum, managing conditions like insomnia, narcolepsy, and restless legs syndrome involves a patient-centered approach that begins with behavioral interventions and progresses to carefully selected medications. This quiz will test your knowledge on FDA-approved hypnotic agents , treatments for narcolepsy , therapeutic options for restless legs syndrome , and the appropriate use of OTC and herbal products for sleep, preparing you to provide safe and evidence-based care.
1. What is the first-line, foundational treatment for chronic insomnia that should be recommended for all patients?
- A. A prescription benzodiazepine receptor agonist
- B. Cognitive behavioral therapy for insomnia (CBT-I) and proper sleep hygiene
- C. An over-the-counter antihistamine
- D. A low-dose stimulating antidepressant
Answer: B. Cognitive behavioral therapy for insomnia (CBT-I) and proper sleep hygiene
2. A patient asks for an OTC sleep aid. The active ingredient in products like Unisom SleepTabs and ZzzQuil is typically:
- A. Melatonin
- B. Diphenhydramine or Doxylamine
- C. Valerian root
- D. Ibuprofen PM
Answer: B. Diphenhydramine or Doxylamine
3. The non-benzodiazepine hypnotics, or “Z-drugs,” are effective for sleep. What is their primary mechanism of action?
- A. They are positive allosteric modulators at the benzodiazepine site on the GABA-A receptor
- B. They are agonists at melatonin receptors
- C. They are antagonists at orexin receptors
- D. They are antagonists at histamine H1 receptors
Answer: A. They are positive allosteric modulators at the benzodiazepine site on the GABA-A receptor
4. A patient needs a hypnotic for sleep-onset insomnia but must be fully alert for work in 6 hours. Which agent has an ultra-short half-life, making it suitable for this scenario?
- A. Eszopiclone
- B. Zolpidem CR
- C. Zaleplon
- D. Temazepam
Answer: C. Zaleplon
5. Suvorexant (Belsomra) is a hypnotic that works by which novel mechanism?
- A. Potentiating GABA
- B. Agonizing melatonin receptors
- C. Antagonizing orexin receptors to suppress wakefulness
- D. Blocking serotonin reuptake
Answer: C. Antagonizing orexin receptors to suppress wakefulness
6. Which hypnotic agent is not a controlled substance and works by selectively agonizing MT1 and MT2 receptors?
- A. Zolpidem
- B. Eszopiclone
- C. Ramelteon
- D. Suvorexant
Answer: C. Ramelteon
7. A significant counseling point for a patient starting zolpidem is to take it immediately before getting into bed due to the risk of:
- A. Hypertensive crisis
- B. Severe nausea and vomiting
- C. Complex sleep-related behaviors (e.g., sleep-driving)
- D. A severe drug-food interaction
Answer: C. Complex sleep-related behaviors (e.g., sleep-driving)
8. The use of older OTC antihistamines like diphenhydramine for sleep is discouraged in elderly patients due to:
- A. Their high cost.
- B. Their potent anticholinergic side effects.
- C. Their lack of efficacy.
- D. Their abuse potential.
Answer: B. Their potent anticholinergic side effects.
9. Which class of medication is considered first-line for managing the excessive daytime sleepiness associated with narcolepsy?
- A. Benzodiazepines
- B. Wakefulness-promoting agents like modafinil
- C. Tricyclic antidepressants
- D. Orexin receptor antagonists
Answer: B. Wakefulness-promoting agents like modafinil
10. Sodium oxybate (Xyrem) is a highly effective treatment for which specific symptom of narcolepsy?
- A. Insomnia
- B. Sleep paralysis
- C. Cataplexy
- D. Excessive daytime sleepiness
Answer: C. Cataplexy
11. The first-line treatment for Restless Legs Syndrome (RLS) often involves:
- A. High-dose antihistamines.
- B. Dopamine agonists (e.g., pramipexole) or alpha-2-delta ligands (e.g., gabapentin enacarbil).
- C. Benzodiazepine receptor agonists.
- D. Stimulants like methylphenidate.
Answer: B. Dopamine agonists (e.g., pramipexole) or alpha-2-delta ligands (e.g., gabapentin enacarbil).
12. A patient with depression and comorbid insomnia might benefit from a low dose of which sedating antidepressant at bedtime?
- A. Bupropion
- B. Fluoxetine
- C. Trazodone
- D. Sertraline
Answer: C. Trazodone
13. Which Z-drug has the longest half-life, making it suitable for sleep maintenance but also carrying a higher risk of next-day impairment?
- A. Zaleplon
- B. Zolpidem IR
- C. Eszopiclone
- D. Indiplon
Answer: C. Eszopiclone
14. What is a key principle of good “sleep hygiene”?
- A. Using electronic devices in bed until you fall asleep.
- B. Maintaining a consistent sleep-wake schedule, even on weekends.
- C. Drinking a large amount of fluid right before bed.
- D. Taking long naps in the late afternoon.
Answer: B. Maintaining a consistent sleep-wake schedule, even on weekends.
15. A patient should be counseled to avoid which substance when taking any hypnotic due to the risk of additive CNS depression?
- A. Vitamin C
- B. Caffeine
- C. Alcohol
- D. Water
Answer: C. Alcohol
16. Which benzodiazepine is specifically FDA-approved for insomnia and has a relatively short half-life?
- A. Diazepam
- B. Clonazepam
- C. Chlordiazepoxide
- D. Temazepam
Answer: D. Temazepam
17. The use of benzodiazepines for the management of insomnia is generally limited to:
- A. Long-term, indefinite use.
- B. Short-term use, due to the risks of tolerance and dependence.
- C. Use in elderly patients only.
- D. Use in patients with a history of substance abuse.
Answer: B. Short-term use, due to the risks of tolerance and dependence.
18. A patient taking zolpidem reports that the medication is less effective if they take it after a large, high-fat meal. This is due to:
- A. An increase in the drug’s metabolism.
- B. A delay in the drug’s absorption.
- C. A direct chemical reaction with the food.
- D. An increase in the drug’s protein binding.
Answer: B. A delay in the drug’s absorption.
19. What is the primary role of melatonin as an OTC supplement in managing sleep disorders?
- A. It is a potent sedative for middle-of-the-night awakenings.
- B. It can help regulate the circadian rhythm, making it useful for jet lag or sleep-onset insomnia.
- C. It is a powerful muscle relaxant.
- D. It is the most effective treatment for sleep apnea.
Answer: B. It can help regulate the circadian rhythm, making it useful for jet lag or sleep-onset insomnia.
20. The orexin neurotransmitter system is a primary regulator of:
- A. Sleep
- B. Wakefulness
- C. Mood
- D. Appetite
Answer: B. Wakefulness
21. When a patient abruptly stops taking a hypnotic like eszopiclone, they may experience what phenomenon?
- A. Improved sleep quality.
- B. Rebound insomnia.
- C. A reduction in anxiety.
- D. Increased energy the next day.
Answer: B. Rebound insomnia.
22. Which tricyclic antidepressant is approved at very low doses (3mg, 6mg) for sleep maintenance insomnia?
- A. Amitriptyline
- B. Imipramine
- C. Nortriptyline
- D. Doxepin
Answer: D. Doxepin
23. A patient with BPH and insomnia should be counseled to avoid OTC sleep aids containing diphenhydramine because of its:
- A. Stimulant properties.
- B. Anticholinergic properties, which can worsen urinary retention.
- C. Dopaminergic properties.
- D. Serotonergic properties.
Answer: B. Anticholinergic properties, which can worsen urinary retention.
24. The management of sleep-wake disorders is an explicit topic in which Patient Care course?
- A. Patient Care V: Endocrinology and Women’s and Men’s Health
- B. Patient Care VII: Brain and Behavior
- C. Patient Care VI: Skin and Musculoskeletal Disorders
- D. Patient Care IV: Gastrointestinal and Renal Disorders
Answer: B. Patient Care VII: Brain and Behavior
25. A patient should be advised to take ramelteon:
- A. With a high-fat meal to increase absorption.
- B. About 30 minutes before bedtime and not with or immediately after a high-fat meal.
- C. In the morning to prevent daytime sleepiness.
- D. As needed for middle-of-the-night awakenings.
Answer: B. About 30 minutes before bedtime and not with or immediately after a high-fat meal.
26. The term “hypnotic” refers to a class of drugs that:
- A. Reduce anxiety.
- B. Improve mood.
- C. Induce or maintain sleep.
- D. Increase wakefulness.
Answer: C. Induce or maintain sleep.
27. For a patient with both depression and insomnia, the most logical initial approach would be:
- A. Prescribing a separate hypnotic and a stimulating antidepressant.
- B. Choosing a sedating antidepressant like trazodone or mirtazapine to address both conditions.
- C. Prescribing a benzodiazepine only.
- D. Focusing only on sleep hygiene.
Answer: B. Choosing a sedating antidepressant like trazodone or mirtazapine to address both conditions.
28. Which of the following is an example of good sleep hygiene?
- A. Exercising vigorously right before bed.
- B. Having a large, heavy meal just before sleep.
- C. Ensuring the bedroom is dark, quiet, and cool.
- D. Watching television in bed to relax.
Answer: C. Ensuring the bedroom is dark, quiet, and cool.
29. The primary safety concern with sodium oxybate is its high potential for abuse and:
- A. Severe liver toxicity.
- B. Potent CNS and respiratory depression.
- C. Hypertensive crisis.
- D. Agranulocytosis.
Answer: B. Potent CNS and respiratory depression.
30. Before recommending any sleep aid, it is critical for the pharmacist to:
- A. Guarantee the patient will sleep for 8 hours.
- B. Assess for underlying medical or psychiatric conditions that could be causing the insomnia.
- C. Insist on the most expensive option.
- D. Recommend the highest possible dose.
Answer: B. Assess for underlying medical or psychiatric conditions that could be causing the insomnia.
31. Augmentation, a common side effect of long-term dopamine agonist use for RLS, refers to:
- A. The medication becoming more effective over time.
- B. The worsening of RLS symptoms, which start earlier in the day and spread to other body parts.
- C. A complete resolution of symptoms.
- D. The development of tolerance.
Answer: B. The worsening of RLS symptoms, which start earlier in the day and spread to other body parts.
32. The “Beer’s Criteria” lists benzodiazepines and Z-drugs as potentially inappropriate for use in the elderly due to the increased risk of:
- A. Improved cognition.
- B. Falls, fractures, and confusion.
- C. Hypertension.
- D. Weight loss.
Answer: B. Falls, fractures, and confusion.
33. What is the most appropriate management for a patient who develops tolerance to a Z-drug they have been taking nightly?
- A. Continue to increase the dose indefinitely.
- B. Recommend a gradual dose reduction and discontinuation, while reinforcing CBT-I.
- C. Add a second hypnotic from the same class.
- D. Switch to a short-acting barbiturate.
Answer: B. Recommend a gradual dose reduction and discontinuation, while reinforcing CBT-I.
34. The primary role of the pharmacist in OTC management of sleep disorders is:
- A. To sell the most expensive product.
- B. To help the patient select an appropriate product, counsel on its safe use, and identify when a referral to a physician is necessary.
- C. To recommend long-term use of antihistamines for sleep.
- D. To diagnose the underlying cause of the insomnia.
Answer: B. To help the patient select an appropriate product, counsel on its safe use, and identify when a referral to a physician is necessary.
35. A patient reports success with the herbal supplement valerian root for sleep. The pharmacist should counsel them that:
- A. It is a potent, FDA-approved hypnotic.
- B. It is completely free of side effects and drug interactions.
- C. Its quality can be inconsistent, and it may cause a “hangover” effect or, paradoxically, stimulation in some individuals.
- D. It should be combined with alcohol for best results.
Answer: C. Its quality can be inconsistent, and it may cause a “hangover” effect or, paradoxically, stimulation in some individuals.
36. A key part of managing sleep-wake disorders is patient education. This falls under which step of the Pharmacists’ Patient Care Process?
- A. Collect
- B. Assess
- C. Plan
- D. Implement
Answer: D. Implement
37. Which of the following is a key feature of narcolepsy?
- A. An inability to fall asleep at night.
- B. Overwhelming daytime sleepiness and sleep attacks.
- C. An uncontrollable urge to move the legs.
- D. Acting out dreams while asleep.
Answer: B. Overwhelming daytime sleepiness and sleep attacks.
38. The use of benzodiazepines in a patient with untreated sleep apnea is dangerous because they can:
- A. Improve breathing during sleep.
- B. Worsen respiratory depression and apnea episodes.
- C. Cure sleep apnea.
- D. Reduce daytime sleepiness.
Answer: B. Worsen respiratory depression and apnea episodes.
39. A patient’s hypnotic should be tapered upon discontinuation to prevent:
- A. A severe hypertensive crisis.
- B. Liver damage.
- C. Rebound insomnia and other withdrawal effects.
- D. An increase in medication cost.
Answer: C. Rebound insomnia and other withdrawal effects.
40. Why is buspirone not effective for insomnia?
- A. It is a CNS stimulant.
- B. It lacks any significant sedative or hypnotic properties.
- C. Its half-life is too long.
- D. It must be taken with food.
Answer: B. It lacks any significant sedative or hypnotic properties.
41. The management of shift work sleep disorder often involves:
- A. Taking a long nap immediately before a night shift.
- B. Using short-acting hypnotics for sleep during the day and wakefulness-promoting agents (e.g., modafinil) during the night shift.
- C. Drinking large amounts of coffee throughout the shift.
- D. Avoiding all light exposure during the day.
Answer: B. Using short-acting hypnotics for sleep during the day and wakefulness-promoting agents (e.g., modafinil) during the night shift.
42. The “Assess” step of the PPCP for a patient with insomnia involves:
- A. Immediately recommending a product.
- B. Evaluating the patient’s symptoms, medication history, and lifestyle to identify potential causes and medication therapy problems.
- C. Dispensing the prescription as written.
- D. Documenting the encounter.
Answer: B. Evaluating the patient’s symptoms, medication history, and lifestyle to identify potential causes and medication therapy problems.
43. The FDA warns that taking a Z-drug with which other class of CNS depressants has led to deaths?
- A. Statins
- B. Opioids
- C. Proton pump inhibitors
- D. Beta-blockers
Answer: B. Opioids
44. Which of the following should be ruled out before diagnosing primary RLS?
- A. Hypertension
- B. Iron deficiency anemia
- C. Hyperlipidemia
- D. Gout
Answer: B. Iron deficiency anemia
45. A patient should be counseled to have at least how many hours available for sleep after taking eszopiclone?
- A. 4 hours
- B. 5 hours
- C. 6 hours
- D. 7-8 hours
Answer: D. 7-8 hours
46. A patient is taking modafinil for narcolepsy. What is a key counseling point regarding its interaction with hormonal contraceptives?
- A. It will increase the efficacy of the contraceptive.
- B. It can decrease the efficacy of hormonal contraceptives by inducing their metabolism.
- C. There is no interaction.
- D. It should only be taken with progestin-only contraceptives.
Answer: B. It can decrease the efficacy of hormonal contraceptives by inducing their metabolism.
47. Low-dose doxepin’s hypnotic effect is due to its high potency as a(n):
- A. Serotonin reuptake inhibitor.
- B. Histamine H1 receptor antagonist.
- C. Norepinephrine reuptake inhibitor.
- D. Dopamine receptor agonist.
Answer: B. Histamine H1 receptor antagonist.
48. What is the most common reason for treatment failure in insomnia?
- A. The medications are not effective.
- B. Failure to address poor sleep hygiene and underlying behavioral factors.
- C. The medications are too expensive.
- D. Patients develop tolerance too quickly.
Answer: B. Failure to address poor sleep hygiene and underlying behavioral factors.
49. For which hypnotic is there a specific warning about performing activities the next day that require full mental alertness, even if the patient feels fully awake?
- A. Diphenhydramine
- B. Melatonin
- C. Suvorexant
- D. Valerian root
Answer: C. Suvorexant
50. The comprehensive management of sleep-wake disorders requires the pharmacist to:
- A. Focus only on dispensing the medication.
- B. Act as an educator, counselor, and collaborator within the healthcare team to optimize both non-pharmacological and pharmacological therapy.
- C. Only recommend OTC products.
- D. Defer all questions to the physician.
Answer: B. Act as an educator, counselor, and collaborator within the healthcare team to optimize both non-pharmacological and pharmacological therapy.
